Skip to main content
. 2023 Jan 1;11(1):109. doi: 10.3390/biomedicines11010109

Figure 2.

Figure 2

Figure 2

Frequency of PI3K/AKT/mTOR mutations in different breast cancer subtypes: (A) HR positive HER2 negative BC, (B) TNBC and (C) HER2 positive BC, respectively.